Travere Therapeutics TVTX

$ 66.07 1.21%

Quarterly report 2026-Q2
added 08-04-2026

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	89.2 M
Market Cap^[1]	$ 5.89 B
EBITDA (LTM)	$ -2.08 M
P/E (LTM)	-225.103448
P/S (LTM)	11.867566
EPS (LTM)	-0.29

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.